ArticleActa pharmaceutica Sinica. B2026

Design, preclinical evaluation, and multicenter phase 1 clinical study of HZ-A-018 for relapsed or refractory central nervous system lymphoma.

Shenglan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.